
According to research from eMarketer the pharmaceutical industry has lagged behind mainstream consumer marketers when it comes to using the Internet to reach patients and drive new Rx's.
(Feb 19, 2009)The news earlier this week that Pfizer was stopping development on two late stage drugs in development should be a warning on what's coming.
(Feb 25, 2009)According to Hit-Wise the number one upstream search is for health information (44.5%) up 11% from last January. What does this data tell us?
(Feb 26, 2009)Over the years in working in the health field I have always believed that if you develop good drugs and take care of patients that profits will naturally follow.
(Mar 10, 2009)I don't think there is a term that is as overhyped as "social media".
(Mar 20, 2009)A survey conducted by Consumer Reports had some frightening information: Nearly 70 percent of the survey respondents who regularly take prescription medications took steps to afford their drugs in the
(Mar 20, 2009)Kevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs